JOURNEY MEDICAL CORP (DERM)
US48115J1097 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to DERM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.99. This target is 135% above the current price.
DERM was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about DERM.
In the previous month the buy percentage consensus was at a similar level.
DERM was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-02-16 | Alliance Global Partners | Initiate | Buy |
| 2023-09-07 | B. Riley Securities | Reiterate | Buy -> Buy |
| 2023-07-12 | B. Riley Securities | Maintains | Buy -> Buy |
| 2023-05-23 | B. Riley Securities | Maintains | Buy -> Buy |
| 2023-03-30 | B. Riley Securities | Reiterate | Buy |
| 2022-02-25 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-12-16 | Roth Capital | Initiate | Buy |
| 2021-12-07 | B. Riley Securities | Initiate | Buy |